Cdk5: A new player at synapses

NeuroSignals

Volumn 12, Issue 4-5, 2003, Pages 180-190

  Cheng, Kai ^a   Ip, Nancy Y ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Cdk5; Cyclin; NMJ; P35; Synapse

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMINO ACID DERIVATIVE; BUTYROLACTONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; DOPAMINE; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; HYBRID PROTEIN; N ETHYLMALEIMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN DARPP 32; PROTEIN P35; PROTEIN P39; SNARE PROTEIN; SYNTAXIN; UNCLASSIFIED DRUG;

BRAIN FUNCTION; BRAIN SYNAPTOSOME; CELL MIGRATION; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME BINDING; ENZYME MECHANISM; ENZYME REGULATION; ENZYME SPECIFICITY; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; ENDOCYTOSIS; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER AGENTS; RECEPTORS, NEUROTRANSMITTER; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 0348010575     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074619     Document Type: Review

References (109)

1. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH: A brain-specific activator of cyclin-dependent kinase 5. Nature 1994;371:423-426.
2. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E: p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994;371:419-423.
3. Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, Hatase O, Wang JH: An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 1995;270:26897-26903.
4. Zheng M, Leung CL, Liem RK: Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J Neurobiol 1998;35:141-159.
5. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB: Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 1996;93:11173-11178.
6. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH: Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defeats, seizures and adult lethality. Neuron 1997;18:29-42.
7. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH: p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 2001;21:6758-6771.
8. Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH: The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 1996;10:816-825.
9. Nikolic M, Chou MM, Lu W, Mayer BJ, Tsai LH: The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 1998;395:194-198.
10. Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG: Phosphorylation of human τ protein by microtubule-associated kinases: GSK3β and cdk5 are key participants. J Neurosci Res 2000;62:463-472.
11. Patrick GN, Zukerberg L, Nikolic M, Monte SDL, Dikkes P, Tsai LH: Conversion of p35 to p25 deregulates cdk5 activity and promotes neurodegeneration. Nature 1999;402:615-622.
12. Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN: Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 1999;34:21-29.
13. Nguyen MD, Larivière RC, Julien JP: Deregulation of cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001;30:135-147.
14. Lew J, Beaudette K, Litwin CM, Wang JH: Purification and characterization of a novel proline-directed kinase from bovine brain. J Biol Chem 1992;267:13383-13390.
15. Morgan DO: Principles of Cdk regulation. Nature 1995;374:131-134.
16. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992;71:505-514.
17. Miyajima M, Nornes HO, Neuman T: Cyclin E is expressed in neurons and forms complexes with cdk5. Neuroreport 1995;6:1130-1132.
18. Brown NR, Noble ME, Endicott JA, Garman EF, Wakatsuki S, Mitchell E, Rasmussen B, Hunt T, Johnson LN: The crystal structure of cyclin A. Structure 1995;3:1235-1247.
19. Tang D, Chun AC, Zhang M, Wang JH: Cyclin-dependent kinase 5 (Cdk5) activation domain of neuronal Cdk5 activator. Evidence of the existence of cyclin fold in neuronal Cdk5a activator. J Biol Chem 1997;272:12318-12327.
20. Humbert S, Lanier LM, Tsai LH: Synaptic localization of p39, a neuronal activator of Cdk5. Neuroreport 2000;11:2213-2216.
21. Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, Morabito M, Tsai LH: Nudel is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 2000;28:697-711.
22. Fu AKY, Fu WY, Cheung J, Tsim KW, Ip FC, Wang JH, Ip NY: Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 2001;4:374-381.
23. Gong X, Tang X, Wiedmann M, Wang X, Peng J, Zheng D, Blair LA, Marshall J, Mao Z: Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 2003;38:33-46.
24. Fu AKY, Fu WY, Ng AKY, Chien WWY, Ng YP, Wang JH, Ip NY: Cdk5 phosphorylates STAT3 and regulates its transcriptional activity (submitted).
25. Gu Y, Rosenblatt J, Morgan DO: Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 1992;11:3995-4005.
26. Poon RY, Lew J, Hunter T: Identification of functional domains in the neuronal Cdk5 activator protein. J Biol Chem 1997;272:5703-5708.
27. Qi Z, Huang QQ, Lee KY, Lew J, Wang JH: Reconstitution of neuronal Cdc2-like kinase from bacteria-expressed Cdk5 and an active fragment of the brain-specific activator. Kinase activation in the absence of Cdk5 phosphorylation. J Biol Chem 1995;270:10847-10854.
28. nck5a complex. Mol Cell 2001;8:657-669.
29. Matsuura I, Wang JH: Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus. J Biol Chem 1996;271:5443-5450.
30. Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, Gertler FB, Vidal M, Van Etten RA, Tsai LH: Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 2000;26:633-646.
31. Lee MH, Nikolic M, Baptista CA, Lai E, Tsai LH, Massague J: The brain-specific activators p35 allows cdk5 to escape inhibition by p27Kip1 in neurons. Proc Natl Acad Sci USA 1996;93:3259-3263.
32. Dhavan R, Tsai LH: A decade of Cdk5. Nat Rev Mol Cell Biol 2001;2:749-759.
33. Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K: Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci 1998;18:6370-6377.
34. Ohshima T, Gilmore EC, Longenecker G, Jacobowitz DM, Brady RO, Herrup K, Kulkarni AB: Migration defects of Cdk5(-/-) neurons in the developing cerebellum is cell autonomous. J Neurosci 1999;19:6017-6026.
35. -/- mice distinct from reeler. J Comp Neurol 1998;395:510-522.
36. Smith DS, Tsai LH: Cdk5 behind the wheel: A role in trafficking and transport? Trends Cell Biol 2002;12:28-36.
37. Chen C, Tonegawa S: Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain. Annu Rev Neurosci 1997;20:157-184.
38. Cohen-Cory S: The developing synapse: Construction and modulation of synaptic structures and circuits. Science 2002;298:770-776.
39. Sanes JR, Lichtman JW: Development of the vertebrate neuromuscular junction. Annu Rev Neurosci 1999;22:389-442.
40. Bowe MA, Fallon JR: The role of agrin in synapse formation. Annu Rev Neurosci 1995;18:443-462.
41. Wallace BG: Aggregating factor from Torpedo electric organ induces patches containing acetylcholine receptors, acetylcholinesterase and butyrylcholinesterase on cultured myotubes. J Cell Biol 1986;102:783-794.
42. Meier T, Hauser DM, Chiquet M, Landmann L, Ruegg MA, Brenner HR: Neural agrin induces ectopic postsynaptic specializations in innervated muscle fibers. J Neurosci 1997;17:6534-6544.
43. Valenzuela DM, Stitt TN, DiStefano PS, Rojas E, Mattsson K, Compton DL, Nunez L, Park JS, Stark JL, Geis DR: Receptor-tyrosine kinase specific for the skeletal muscle lineage: Expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 1995;15:573-584.
44. Glass DJ, Bowen DC, Stitt TN, Radziejewski C, Bruno J, Ryan TE, Gies DR, Shah S, Mattsson K, Burden SJ, DiStefano PS, Valenzuela DM, DeChiara TM, Yancopoulos GD: Agrin acts via a MuSK receptor complex. Cell 1996;85:513-523.
45. Chu GC, Moscoso LM, Sliwkowski MX, Merlie JP: Regulation of the acetylcholine receptor ε subunit gene by recombinant ARIA: An in vitro model for transynaptic gene regulation. Neuron 1995;14:329-339.
46. Sandrock AW Jr, Dryer SE, Rosen KM, Gozani SN, Kramer R, Theill LE, Fischbach GD: Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. Science 1997;276:599-603.
47. Sanes JR: Genetic analysis of postsynaptic differentiation at the vertebrate neuromuscular junction. Curr Opin Neurobiol 1997;7:93-100.
48. Carraway KL III, Burden SJ: Neuregulins and their receptors. Curr Opin Neurobiol 1995;5:600-612.
49. Lai KO, Ip NY: Central synapse and neuromuscular junction: Same players, different roles. Trends Genet 2003;19:395-402.
50. Fu WY, Wang JH, Ip NY: Expression of Cdk5 and its activators in NT2 cells during neuronal differentiation. J Neurochem 2002;81:646-654.
51. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, Kulkarni AB, Brady RO, Pant HC: Regulation of NMDA receptors by cyclin-dependent kinase 5. Proc Natl Acad Sci USA 2001;98:12742-12747.
52. Bennett MK, Scheller RH: The molecular machinery for secretion is conserved from yeast to neurons. Proc Natl Acad Sci USA 1993;90:2559-2563.
53. Sollner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothman JE: SNAP receptors implicated in vesicle targeting and fusion. Nature 1993;362:318-324.
54. Sudhof TC, De Camilli P, Niemann H, Jahn R: Membrane fusion machinery: Insights from synaptic proteins. Cell 1993;75:1-4.
55. Rothman JE: Mechanisms of intracellular protein transport. Nature 1994;372:55-63.
56. Schekman R: Genetic and biochemical analysis of vesicular traffic in yeast. Curr Opin Cell Biol 1992;4:587-592.
57. Shuang R, Zhang L, Fletcher A, Groblewski GE, Pevsner J, Stuenkel EL: Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J Biol Chem 1998;273:4957-4966.
58. Fletcher AI, Shuang R, Giovannucci DR, Zhang L, Bittner MA, Stuenkel EL: Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J Biol Chem 1999;274:4027-4035.
59. 2+ channels and their role in neurotransmitter release. Cell Calcium 1998;24:307-323.
60. Westenbroek RE, Sakurai T, Elliott EM, Hell JW, Starr TV, Snutch TP, Catterall WA: Immunochemical identification and subcellular distribution of the α1A subunits of brain calcium channels. J Neurosci 1995;15:6403-6418.
61. Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K, Matsui H: Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci 2002;22:2590-2597.
62. Greengard P, Valtorta F, Czernik AJ, Benfenati F: Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 1993;259:780-785.
63. Matsubara M, Kusubata M, Ishiguro K, Uchida T, Titani K, Taniguchi H: Site-specific phosphorylation of synapsin 1 by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J Biol Chem 1996;271:21108-21113.
64. Fon EA, Edwards RH: Molecular mechanisms of neurotransmitter release. Muscle Nerve 2001;24:581-601.
65. Cremona O, De Camilli P: Synaptic vesicle endocytosis. Curr Opin Neurobiol 1997;7:323-330.
66. Floyd SR, Porro EB, Slepnev VI, Ochoa GC, Tsai LH, De Camilli P: Amphiphysin 1 binds the cyclin-dependent kinase (Cdk) 5 regulatory subunit p35 and is phosphorylated by Cdk5 and Cdc2. J Biol Chem 2001;276:8104-8110.
67. Rosales JL, Nodwell MJ, Johnston RN, Lee KY: Cdk5/p25(nck5a) interaction with synaptic proteins in bovine brain. J Cell Biochem 2000;78:151-159.
68. Lichte B, Veh RW, Meyer HE, Kilimann MW: Amphiphysin, a novel protein associated with synaptic vesicles. EMBO J 1992;11:2521-2530.
69. De Camilli P, Thomas A, Cofiell R, Folli F, Lichte B, Piccolo G, Meinck HM, Austoni M, Fassetta G, Bottazzo G, Bates D, Cartlidge N, Solimena M, Kilimann MW: The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med 1993;178:2219-2223.
70. David C, McPherson PS, Mundigl O, de Camilli P: A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. Proc Natl Acad Sci USA 1996;93:331-335.
71. Shupliakov O, Low P, Grabs D, Gad H, Chen H, David C, Takei K, De Camilli P, Brodin L: Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. Science 1997;276:259-263.
72. Slepnev VI, Ochoa GC, Butler MH, Grabs D, Camilli PD: Role of phosphorylation in regulation of the assembly of endocytic coat complexes. Science 1998;281:821-824.
73. Di Paolo G, Sankaranarayanan S, Wenk MR, Daniell L, Perucco E, Caldarone BJ, Flavell R, Picciotto MR, Ryan TA, Cremona O, De Camilli P: Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin-1 knockout mice. Neuron 2002;33:789-804.
74. Lee J, Colwill K, Aneliunas V, Tennyson C, Moore L, Ho Y, Andrews B: Interaction of yeast Rvs167 and Pho85 cyclin-dependent kinase complexes may link the cell cycle to the actin cytoskeleton. Curr Biol 1998;8:1310-1321.
75. Sheng M, Kim MJ: Postsynaptic signaling and plasticity mechanisms. Science 2002;298:776-780.
76. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S: Molecular cloning and characterization of the rat NMDA receptor. Nature 1991;354:31-37.
77. Ryan TA, Ziv NE, Smith SJ: Potentiation of evoked vesicle turnover at individually resolved synaptic boutons. Neuron 1996;17:125-134.
78. Hollmann M, Heinemann S: Cloned glutamate receptors. Annu Rev Neurosci 1994;17:31-108.
79. Zukin RS, Bennett MV: Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 1995;18:306-313.
80. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H et al: Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit. Nature 1995;373:151-155.
81. 2+/calmodulin-dependent protein kinase II and α-actinin-1 in a calcium-dependent manner. J Neurosci 2002;22:7879-7891.
82. Conn PJ, Pin JP: Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-237.
83. Nakanishi S, Nakajima Y, Masu M, Ueda Y, Nakahara K, Watanabe D, Yamaguchi S, Kawabata S, Okada M: Glutamate receptors: Brain function and signal transduction. Brain Res Brain Res Rev 1998;26:230-235.
84. Liu F, Ma XH, Ule J, Bibb JA, Nishi A, DeMaggio AJ, Yan Z, Nairn AC, Greengard P: Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc Natl Acad Sci USA 2001;98:11062-11068.
85. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC Jr, Nairn AC, Greengard P: Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signaling in neurons. Nature 1999;402:669-671.
86. Greengard P: The neurobiology of slow synaptic transmission. Science 2001;294:1024-1030.
87. Hemmings HC Jr, Greengard P, Tung HY, Cohen P: DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 1984;310:503-505.
88. Greengard P, Allen PB, Nairn AC: Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade. Neuron 1999;23:435-447.
89. Bibb JA, Nishi A, O'Callaghan JP, Ule J, Lan M, Snyder GL, Horiuchi A, Saito T, Hisanaga S, Czernik AJ, Nairn AC, Greengard P: Phosphorylation of protein phosphatase inhibitor-1 by Cdk5. J Biol Chem 2001;276:14490-14497.
90. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P: Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001;410:376-380.
91. Huber AH, Stewart DB, Laurents DV, Nelson WJ, Weis WI: The cadherin cytoplasmic domain is unstructured in the absence of β-catenin: A possible mechanism for regulating cadherin turnover. J Biol Chem 2001;276:12301-12309.
92. Kwon YT, Gupta A, Zhou Y, Nikolic M, Tsai L-H: Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr Biol 2000;10:363-372.
93. Kesavapany S, Lau KF, McLoughlin DM, Brownlees J, Ackerley S, Leigh PN, Shaw CE, Miller CC: p35/Cdk5 binds and phosphorylates β-catenin and regulates β-catenin/presenilin-1 interaction. Eur J Neurosci 2001;13:241-247.
94. Tang L, Hung CP, Schuman EM: A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation. Neuron 1998;20:1165-1175.
95. Bozdagi O, Shan W, Tanaka H, Benson DL, Huntley GW: Increasing numbers of synaptic puncta during late-phase LTP: N-cadherin is synthesized, recruited to synaptic sites, and required for potentiation. Neuron 2000;28:245-259.
96. Schuman EM, Murase S: Cadherins and synaptic plasticity: Activity-dependent cyclin-dependent kinase 5 regulation of synaptic beta-catenin-cadherin interactions. Philos Trans R Soc Lond B Biol Sci 2003;358:749-756.
97. Si J, Luo Z, Mei L: Induction of acetylcholine receptor gene expression by ARIA requires activation of mitogen-activated protein kinase. J Biol Chem 1996;271:19752-19759.
98. Si J, Wang Q, Mei L: Essential roles of c-JUN and c-JUN N-terminal kinase (JNK) in neuregulin-increased expression of the acetylcholine receptor epsilon-subunit. J Neurosci 1999;19:8498-8508.
99. Tansey MG, Chu GC, Merlie JP: ARIA/HRG regulates AChR ε-subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and Ras/MAPK pathway. J Cell Biol 1996;134:465-476.
100. Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, Pelkey KA, Yang DJ, Xiong WC, Salter MW, Mei L: Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000;26:443-455.
101. Cheng K, Li Z, Fu WY, Wang JH, Fu AK, Ip NY: Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35. J Biol Chem 2002;277:31988-31993.
102. Graeser R, Gannon J, Poon RY, Dubois T, Aitken A, Hunt T: Regulation of the CDK-related protein kinase PCTAIRE-1 and its possible role in neurite outgrowth in Neuro-2A cells. J Cell Sci 2002;115:3479-3490.
103. Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, Chernoff J: Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr Biol 1997;7:202-210.
104. Hall A: Rho GTPases and the actin cytoskeleton. Science 1998;279:509-514.
105. Weston C, Yee B, Hod E, Prives J: Agrin-induced acetylcholine receptor clustering is mediated by the small guanosine triphosphatases Rac and Cdc42. J Cell Biol 2000;150:205-212.
106. Weston C, Gordon C, Teressa G, Hod E, Ren XD, Prives J: Cooperative regulation by Rac and Rho of agrin-induced acetylcholine receptor clustering in muscle cells. J Biol Chem 2003;278:6450-6455.
107. Luo ZG, Wang Q, Zhou JZ, Wang J, Luo Z, Liu M, He X, Wynshaw-Boris A, Xiong WC, Lu B, Mei L: Regulation of AChR clustering by dishevelled interacting with MuSK and PAK1. Neuron 2002;35:489-505.
108. Fu AKY, Ip FCF, Cheung J, Wang JH, Fu WY, Ip NY: Cdk5 regulates motor axon growth and AChR clustering at the developing neuromuscular junction (submitted).
109. Fu WY, Fu AK, Lok KC, Ip FC, Ip NY: Induction of Cdk5 activity in rat skeletal muscle after nerve injury. Neuroreport 2002;13:243-247.